Evaxion A/s cash flow statement

In fiscal 2025, Evaxion A/s's operations generated −$6.6m of cash; it spent $11,000 on capital projects, leaving free cash flow of −$6.6m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Evaxion A/s: cash flow statement, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	−26	−18	−13	−7
Depreciation and amortisation	1	1	1	—
Stock-based pay	1	0	0	0
Capital spending	0	0	0	0
Free cash flow	−26	−18	−13	−7
Free cash flow after stock pay	−27	−18	−13	−7

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: EVAX vs ROIV ADAG vs EVAX EVAX vs TCRX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Evaxion A/s's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Evaxion A/s.